drugset / Trial / NCT07734610
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy participants.
Timeline
- Start
- 2026-09-08
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nemtabrutinib | Other / unclassified | — | Oral |
Indications
No indication recorded.